Default company panoramic image
B855d95c 71ba 4566 9127 7fff60a29495

Madera BioSciences, Inc.

First effective Alzheimer's drug will be an costly antibody. Madera is the small molecule alternative for cost-effective long-term therapy.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Rancho Santa Fe, CA, USA
  • Currency USD
  • Founded June 2008
  • Employees 2
  • Website maderabiosciences.com

Company Summary

Madera BioSciences is a startup biotechnology company founded by Edwin Iwanowicz, Ph.D. in 2008. The company provides innovative small molecule experimental therapeutics for the treatment of Alzheimer’s disease to pharma companies. Madera’s technology niche is to clear a key pathogen protein, amyloid beta. Our intellectual property resulted from a successful collaboration with Eli Lilly. The company have raised > $640K and seeks $2M.

Team

  • Default avatar
    Richard M Jack
    President and CEO

  • Default avatar
    Spencer David Kimball
    Senior Advisor, Drug Discovery

  • Default avatar
    Edwin J. Iwanowicz
    Founder

Advisors

  • Default avatar
    WilmerHale
    Lawyer
    Unconfirmed
    Default avatar
    CD Geidt
    Accountant
    Unconfirmed